International Assets Investment Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

International Assets Investment Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,301	Closed	-$165K	–	1706
2024 Q3	$165K	Buy	+3,301	New	+$120K	0.01%	664
2023 Q1	–	Sell	-5,425	Closed	-$202K	–	1342
2022 Q4	$202K	Buy	+5,425	New	+$163K	0.02%	622
2021 Q2	–	Sell	-182	Closed	-$9K	–	1629
2021 Q1	$9K	Hold	182	–	–	﹤0.01%	1606
2020 Q4	$9K	Buy	+182	New	+$8.66K	﹤0.01%	1472

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PWA

Phoenix Wealth Advisors Chapel Hill, North Carolina $297M AUM 17.87% 1-Year Est. Return

International Assets Investment Management's SBIO Position: Q4 2024 in Review

International Assets Investment Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2024, closing a stake of 3,301 shares — an estimated $165K sold.

International Assets Investment Management first reported a position in SBIO in Q4 2020 and held it in 4 quarters. The position peaked at $202K in Q4 2022. 36 funds tracked by Wall St. Rank hold SBIO as of Q4 2024.

International Assets Investment Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2024 after selling out during the quarter.
International Assets Investment Management sold 3,301 ALPS Medical Breakthroughs ETF shares in Q4 2024, an estimated $165K.
International Assets Investment Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2020 and held it in 4 quarters.
International Assets Investment Management's ALPS Medical Breakthroughs ETF position peaked at $202K in Q4 2022.
36 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.